Market Research Logo

Europe Acute Myeloid Leukemia Market and Competitive Landscape – 2017

Europe Acute Myeloid Leukemia Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Acute Myeloid Leukemia Market and Competitive Landscape – 2017, provides comprehensive insights into Acute Myeloid Leukemia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Acute Myeloid Leukemia market size and drug sales. This research also provides insights into Acute Myeloid Leukemia epidemiology and late stage pipeline.
The report is classified into nine sections – Acute Myeloid Leukemia overview with definitions, symptoms, etiology, diagnosis, treatment options; Acute Myeloid Leukemia pipeline insights covering late stage clinical trials pipeline; Acute Myeloid Leukemia prevalence trends by countries; Acute Myeloid Leukemia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Acute Myeloid Leukemia pipeline: Find out the drugs in clinical trials for Acute Myeloid Leukemia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Acute Myeloid Leukemia epidemiology: Find out the prevalence of Acute Myeloid Leukemia by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Acute Myeloid Leukemia products: Identify key products marketed and prescribed for Acute Myeloid Leukemia by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Acute Myeloid Leukemia market size: Find out the market size for Acute Myeloid Leukemia drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Acute Myeloid Leukemia drug sales: Find out the sales of Acute Myeloid Leukemia drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Acute Myeloid Leukemia drugs sales forecast: Sales forecast for Acute Myeloid Leukemia drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Acute Myeloid Leukemia market share analysis: Find out the market shares of Acute Myeloid Leukemia drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Acute Myeloid Leukemia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Acute Myeloid Leukemia market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Acute Myeloid Leukemia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Acute Myeloid Leukemia: Disease Overview
1.1. Acute Myeloid Leukemia Symptoms
1.2. Acute Myeloid Leukemia Etiology
1.3. Acute Myeloid Leukemia Diagnosis
1.4. Acute Myeloid Leukemia Treatment Options
2. Acute Myeloid Leukemia Pipeline Insights
2.1. Acute Myeloid Leukemia Phase 3 Clinical Trials
2.2. Acute Myeloid Leukemia Phase 2 Clinical Trials
2.3. Acute Myeloid Leukemia Phase 1 Clinical Trials
3. Acute Myeloid Leukemia Epidemiology Analysis
4. Germany Acute Myeloid Leukemia Market Insights
4.1. Marketed Products for Acute Myeloid Leukemia in Germany
4.2. Germany Acute Myeloid Leukemia Market Size & Forecast
4.3. Germany Acute Myeloid Leukemia Product Sales Forecast
4.4. Germany Acute Myeloid Leukemia Market Share Analysis
5. France Acute Myeloid Leukemia Market Insights
5.1. Marketed Products for Acute Myeloid Leukemia in France
5.2. France Acute Myeloid Leukemia Market Size & Forecast
5.3. France Acute Myeloid Leukemia Product Sales Forecast
5.4. France Acute Myeloid Leukemia Market Share Analysis
6. Italy Acute Myeloid Leukemia Market Insights
6.1. Marketed Products for Acute Myeloid Leukemia in Italy
6.2. Italy Acute Myeloid Leukemia Market Size & Forecast
6.3. Italy Acute Myeloid Leukemia Product Sales Forecast
6.4. Italy Acute Myeloid Leukemia Market Share Analysis
7. Spain Acute Myeloid Leukemia Market Insights
7.1. Marketed Products for Acute Myeloid Leukemia in Spain
7.2. Spain Acute Myeloid Leukemia Market Size & Forecast
7.3. Spain Acute Myeloid Leukemia Product Sales Forecast
7.4. Spain Acute Myeloid Leukemia Market Share Analysis
8. UK Acute Myeloid Leukemia Market Insights
8.1. Marketed Products for Acute Myeloid Leukemia in UK
8.2. UK Acute Myeloid Leukemia Market Size & Forecast
8.3. UK Acute Myeloid Leukemia Product Sales Forecast
8.4. UK Acute Myeloid Leukemia Market Share Analysis
9. Europe Acute Myeloid Leukemia Market Insights
9.1. Europe Acute Myeloid Leukemia Market Size & Forecast
9.2. Europe Acute Myeloid Leukemia Product Sales Forecast
9.3. Europe Acute Myeloid Leukemia Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Acute Myeloid Leukemia Phase 3 Clinical Trials, Global, 2017
Table 2: Acute Myeloid Leukemia Phase 2 Clinical Trials, Global, 2017
Table 3: Acute Myeloid Leukemia Phase 1 Clinical Trials, Global, 2017
Table 4: Acute Myeloid Leukemia Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Acute Myeloid Leukemia in Germany, 2017
Table 6: Germany Acute Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 8: Germany Acute Myeloid Leukemia Market Trends, 2012 - 2021
Table 9: Marketed Products for Acute Myeloid Leukemia in France, 2017
Table 10: France Acute Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 12: France Acute Myeloid Leukemia Market Trends, 2012 - 2021
Table 13: Marketed Products for Acute Myeloid Leukemia in Italy, 2017
Table 14: Italy Acute Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 16: Italy Acute Myeloid Leukemia Market Trends, 2012 - 2021
Table 17: Marketed Products for Acute Myeloid Leukemia in Spain, 2017
Table 18: Spain Acute Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 20: Spain Acute Myeloid Leukemia Market Trends, 2012 - 2021
Table 21: Marketed Products for Acute Myeloid Leukemia in UK, 2017
Table 22: UK Acute Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 24: UK Acute Myeloid Leukemia Market Trends, 2012 - 2021
Table 25: Europe Acute Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Acute Myeloid Leukemia Pipeline by Phase (%), Global, 2017
Figure 2: Acute Myeloid Leukemia Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Acute Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 4: Germany Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 5: Germany Acute Myeloid Leukemia Market Share by Products (%), 2016
Figure 6: Germany Acute Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 7: France Acute Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 8: France Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 9: France Acute Myeloid Leukemia Market Share by Products (%), 2016
Figure 10: France Acute Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 11: Italy Acute Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 12: Italy Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 13: Italy Acute Myeloid Leukemia Market Share by Products (%), 2016
Figure 14: Italy Acute Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 15: Spain Acute Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 16: Spain Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 17: Spain Acute Myeloid Leukemia Market Share by Products (%), 2016
Figure 18: Spain Acute Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 19: UK Acute Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 20: UK Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 21: UK Acute Myeloid Leukemia Market Share by Products (%), 2016
Figure 22: UK Acute Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 23: Europe Acute Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 24: Europe Acute Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 25: Europe Acute Myeloid Leukemia Market Share by Products (%), 2016
Figure 26: Europe Acute Myeloid Leukemia Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report